On Cancer: Cancer Immunotherapy & Vaccines

and/or

51 Blog posts found

Finding

Adding Low-Dose Radiation Could Make CAR T Therapy More Effective, Study Finds

The treatment combination appears to boost chimeric antigen receptor (CAR) T cells’ ability to kill cancer cells in solid tumors.

Blue cancer cell with a target on it

In the Clinic

New Study Shows Immunotherapy and Chemo Combination Extends Survival for People with Hard-to-Treat Breast Cancer

MSK experts comment on a new international study that looked at combination therapy for triple-negative breast cancer.

Elizabeth Comen with a patient

In the News

Former MSK Immunologist James Allison Wins Nobel Prize in Medicine

Dr. Allison is being honored for discovering how to take the brakes off cancer-fighting immune cells.

James Allison

Q & A

HPV Vaccine and Cancer Risk: Frequently Asked Questions

HPV-associated cancers are on the rise, but only about half of all adolescents in the United States have received the full series of shots. In this Q & A, Chrisann Kyi talks about why it's so important for young people to get vaccinated.

A nurse gives a girl a vaccination.

In the Lab

Putting the STING in Immunotherapy: Research Focuses on Ways to Improve Cancer Treatments

Researchers are looking for ways to make cancer cells more visible to the immune system.

Different viewpoints of the STING pathway

Finding

Discovery of Unusual Cell Type Could Help Guide Immunotherapy

A newly identified group of immunosuppressive cells could provide insight into the effects of immunotherapy drugs.

Scanning electron micrograph (SEM) of T lymphocyte cells (blue) attached to a red cancer cell.

Roundup

Highlights from MSK at the 2018 American Association for Cancer Research Meeting

Read up on the latest developments in several key areas of cancer research, including genomic mapping, disease modeling through CRISPR, CAR T therapy, and cancer stem cells.

Sign for AACR scientific meeting featuring collage of images

In the Clinic

Immunotherapy Combination Is Better than Chemotherapy for Non-Small Cell Lung Cancer

MSK’s Matthew Hellmann led an international, phase III trial looking at the combination of immunotherapy drugs ipilimumab and nivolumab.

MSK medical oncologist Matthew Hellmann

In the Clinic

After Isolated Limb Infusion, People with Melanoma Get a Second Chance at Life

Meet three people who were treated as part of a clinical trial for melanoma at Memorial Sloan Kettering.

In the Clinic

Chemotherapy-Immunotherapy Combination Aims to Knock Out Melanoma with a One-Two Punch

A new approach for treating melanoma combines the immunotherapy drug ipilimumab with chemotherapy that treats only the area affected by cancer.

Jedd Wolchok and Charlotte Ariyan in the lab